The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Systematic Review of Docetaxel, Paclitaxel and Vinorelbine in the Treatment of Advanced Breast Cancer in the UK.
 
Kazuya Yamaguchi
No Relationships to Disclose
 
Kazuhiro Yoshida
Honoraria - Chugai Pharma; Daiichi Sankyo; EA Pharma; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); EA Pharma (Inst); Lilly Japan (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
Travel, Accommodations, Expenses - Chugai Pharma; Daiichi Sankyo; EA Pharma; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Junki Mizusawa
Honoraria - Chugai Pharma
 
Tomonori Mizutani
No Relationships to Disclose
 
Seiji Ito
Honoraria - Chugai Pharma; Lilly; Olympus Medical Systems; Otsuka; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)
 
Yasunori Nishida
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Takeshi Sano
Honoraria - Chugai Pharma; Covidien; Eisai; Ethicon; Lilly; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Mitsuru Sasako
Honoraria - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
 
Hiroshi Katayama
Honoraria - Johnson & Johnson
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Narikazu Boku
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Takaki Yoshikawa
Honoraria - Abbott Nutrition; Ajinomoto; Chugai Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; Medtronic; Nihonkayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Chugai Pharma; MSD Oncology; Novartis
Research Funding - Chugai Pharma; Novartis; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Masanori Terashima
Honoraria - Chugai Pharma; Lilly; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Otsuka (Inst); Yakult Honsha (Inst)